If you or someone you know have been determined with porous bones, it
is not difficult to agree with the presumption that anti-resorptive
drugs such as Fosamax
may have assumed a role in your life. It may be also less difficult to
imagine how you may have come to know the potentially harmful effects
and lawsuits related to the widely distributed drug. The Fosamax Injury Lawsuit Center
features relevant and up-to-date information about
Fosamax and compensatory claims involving the popular osteoporosis
drug’s side effects.
Alongside a medication’s therapeutic effects is the risk of mild to
severe side effects, medical experts say. This scientific notion goes
the same for anti-bone degeneration drugs. Where osteoporosis treatment
is involved, antiresorptive bisphosphonate drugs reportedly became the
mainstay treatment for porous bones, taking the place of hormone therapy
in women, after the introduction of the prime anti-bone loss drug
popularly known as Fosamax.
Otherwise known by its generic equivalent, alendronate, Fosamax is an
anti-osteoporosis drug originally manufactured and distributed by
American pharmaceutical firm, Merck & Co. As soon as the medication
was released in late 1995, Fosamax reportedly emerged as one of the
most prescribed formulations nationwide, being the pioneering
osteoporosis medication to be sold in the United States market.
Much like other bisphosphonates, Fosamax primarily functions by slowing down the rate of bone loss by changing the cycle of bone breakdown
and formation, which in turn decreases a patient’s fractural risk, the
most dire consequence of osteoporosis. It was indicated to prevent and
treat porous bones in older men and ageing women beyond their menopause,
including patients with secondary osteoporosis from the long-term use
of steroids. Fosamax is also known to increase bone mineral density in
men with osteoporosis, and used to treat Paget\\’s disease of the bone
in men and women.
Although most patients reported a high threshold toward the common
side effects of Fosamax, rare yet potentially serious side effects,
including thighbone fractures and a rare jaw disease known as
osteonecrosis of the jaw, have also been tied to Fosamax use. Current
researchers also show a growing number of scientific evidences
demonstrating a possible link between Fosamax and esophageal cancer, as
well as atrial fibrillation (irregular heart rhythms).